Citations

Showing 10 of 108094 citations.

In Response
McMullen, Kaley, Harbell, Monica W. , Kraus, Molly B.

Mayo Clinic

Anesthesia & Analgesia | September 15, 2022 | Volume: 135 | Issue: 4 | Pages: e22-e23

10.1213/ane.0000000000006143 | PMID 36108195 Get It

Post-discharge early assessment with remote video link (PEARL) initiative for patients discharged from hospital medicine services
Dugani, Sagar B. , Kiliaki, Shangwe A. , Nielsen, Megan , Coons, Trevor J. , Fischer, Karen M. , Parikh, Riddhi S. , Pagali, Sandeep R. , Liwonjo, Anne , Schroeder, Darrell R. , Croghan, Ivana T. , Burton, M. Caroline , Nielsen, Megan L , Pagali, Sandeep , Fischer, Karen M , Coons, Trevor , Kiliaki, Shangwe , Schroeder, Darrell , Dugani, Sagar B

Mayo Clinic

Hospital Practice | September 15, 2022 | Volume: 50 | Issue: 5 | Pages: 379-386

10.1080/21548331.2022.2125726 | PMID 36107464 Get It

Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia
Zhao, Na , Qiao, Wenhui , Li, Fuyao , Ren, Yingxue , Zheng, Jiaying , Martens, Yuka A. , Wang, Xusheng , Li, Ling , Liu, Chia‐Chen , Chen, Kai , Zhu, Yiyang , Ikezu, Tadafumi C. , Li, Zonghua , Meneses, Axel , Jin, Yunjung , Chen, Yixing , Sonustun, Berkiye , Job, Lucy , Smith, Madeleine L. , Xie, Manling , Liu, Yong , Umpierre, Anthony D. , Haruwaka, Koichiro , Quicksall, Zachary , Störz, Peter , Asmann, Yan W. , Wu, Long‐Jun , Bu, Guojun , Meneses, Axel D , Knight, Joshua A , Chen, Yixing , Bastea, Ligia , Linares, Cynthia , Sonustun, Berkiye , Job, Lucy , Smith, Madeleine L , Xie, Manling , Liu, Yong U , Umpierre, Anthony D , Haruwaka, Koichiro , Quicksall, Zachary S , Storz, Peter , Asmann, Yan W , Wu, Long-Jun , Bu, Guojun , Liu, Chia-Chen , Zhao, Na , Li, Fuyao , Zheng, Jiaying , Knight, Joshua A. , Bastea, Ligia I.

Mayo Clinic

Journal of Experimental Medicine | September 15, 2022 | Volume: 219 | Issue: 12 | Pages: No page available

10.1084/jem.20212479 | PMID 36107206 Get It

TREM2 is exclusively expressed by microglia in the brain and is strongly linked to the risk for Alzheimer’s disease (AD). As microglial responses modulated by TREM2 are central to AD pathogenesis, enhancing TREM2 signaling has been explored as an AD therapeutic strategy. However, the effective therapeutic window targeting TREM2 is unclear. Here, by using microglia-specific inducible mouse models overexpressing human wild-type TREM2 (TREM2-WT) or R47H risk variant (TREM2-R47H), we show that TREM2-WT expression reduces amyloid deposition and neuritic dystrophy only during the early amyloid seeding stage, whereas TREM2-R47H exacerbates amyloid burden during the middle amyloid rapid growth stage. Single-cell RNA sequencing reveals suppressed disease-associated microglia (DAM) signature and reduced DAM population upon TREM2-WT expression in the early stage, whereas upregulated antigen presentation pathway is detected with TREM2-R47H expression in the middle stage. Together, our findings highlight the dynamic effects of TREM2 in modulating AD pathogenesis and emphasize the beneficial effect of enhancing TREM2 function in the early stage of AD development.
Ultrasound Simulation Training for Radiology Residents—Curriculum Design and Implementation
Alexander, Lauren F. , McComb, Barbara L., Bonnett, Stephanie L., Ghazanfari, Samantha M., Caserta, Melanie P. , Alexander, Lauren F , Bowman, Andrew W. , Bonnett, Stephanie

Mayo Clinic

Journal of Ultrasound in Medicine | September 15, 2022 | Volume: 42 | Issue: 4 | Pages: 777-790

10.1002/jum.16098 | PMID 36106721 Get It

Medical simulation training can be used to improve clinician performance, teach communication and professionalism skills, and enhance team training. Radiology residents can benefit from simulation training in diagnostic ultrasound, procedural ultrasound, and communication skills prior to direct patient care experiences. This paper details a weeklong ultrasound simulation training curriculum for radiology residents during the PGY‐1 clinical internship. The organization of established teaching methods into a dedicated course early in radiology residency training with the benefit of a multi‐disciplinary approach makes this method unique. This framework can be adapted to fit learners at different skill levels or with specific procedural needs.
The scenic route: dilated left superior intercostal vein following acute left brachiocephalic venous obstruction
Tan, Nicholas Y. , Deshmukh, Abhishek , Deshmukh, Abhishek J

Mayo Clinic

EP Europace | September 15, 2022 | Volume: 25 | Issue: 1 | Pages: 39-39

10.1093/europace/euac120 | PMID 36106678 Get It

Quantitative Anatomic Comparison of Endoscopic Transnasal and Microsurgical Transcranial Approaches to the Anterior Cranial Fossa
Agosti, Edoardo , Rampinelli, Vittorio , Veiceschi, Pierlorenzo , Giorgianni, Andrea , Alexander, A. Yohan , Piazza, Cesare , Nicolai, Piero , Peris‐Celda, Maria , Doglietto, Francesco , Alexander, Alex Yohan, Agosti, Edoardo , Doglietto, Francesco , Saraceno, Giorgio , Raffetti, Elena , Buffoli, Barbara , Rezzani, Rita , Hirtler, Lena , Alexander, A Yohan , Deganello, Alberto , Castelnuovo, Paolo , Locatelli, Davide , Fontanella, Marco Maria

Mayo Clinic

Operative Neurosurgery | September 15, 2022 | Volume: 23 | Issue: 4 | Pages: e256-e266

10.1227/ons.0000000000000312 | PMID 36106936 Get It

BACKGROUND: Several microsurgical transcranial approaches (MTAs) and endoscopic transnasal approaches (EEAs) to the anterior cranial fossa (ACF) have been described. OBJECTIVE: To provide a preclinical, quantitative, anatomic, comparative analysis of surgical approaches to the ACF. METHODS: Five alcohol-fixed specimens underwent high-resolution computed tomography. The following approaches were performed on each specimen: EEAs (transcribriform, transtuberculum, and transplanum), anterior MTAs (transfrontal sinus interhemispheric, frontobasal interhemispheric, and subfrontal with unilateral and bilateral frontal craniotomy), and anterolateral MTAs (supraorbital, minipterional, pterional, and frontotemporal orbitozygomatic approach). An optic neuronavigation system and dedicated software (ApproachViewer, part of GTx-Eyes II—UHN) were used to quantify the working volume of each approach and extrapolate the exposure of different ACF regions. Mixed linear models with random intercepts were used for statistical analyses. RESULTS: EEAs offer a large and direct route to the midline region of ACF, whose most anterior structures (ie, crista galli, cribriform plate, and ethmoidal roof) are also well exposed by anterior MTAs, whereas deeper ones (ie, planum sphenoidale and tuberculum sellae) are also well exposed by anterolateral MTAs. The orbital roof region is exposed by both anterolateral and lateral MTAs. The posterolateral region (ie, sphenoid wing and optic canal) is well exposed by anterolateral MTAs. CONCLUSION: Anterior and anterolateral MTAs play a pivotal role in the exposure of most anterior and posterolateral ACF regions, respectively, whereas midline regions are well exposed by EEAs. Furthermore, certain anterolateral approaches may be most useful when involvement of the optic canal and nerves involvement are suspected.
Subacute necrotizing fasciitis of the posterior neck disguised as a herpes zoster infection: A case report
Wright, Samantha-Jo, Bartlett, Brian, Jama, Abbas B, Mushtaq, Hisham, Khan, Syed Anjum , Khedr, Anwar , Bartlett, Brian N., Khedr, Anwar , Wahab, Abdul

Mayo Clinic

SAGE Open Medical Case Reports | September 15, 2022 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/2050313x221123295 | PMID 36147591 Get It

Necrotizing fasciitis is a rare soft tissue infection characterized by a rapidly spreading infection of the subcutaneous tissue. Early diagnosis is important as it requires immediate and complete debridement of infected tissues and antibiotic therapy. Necrotizing fasciitis usually involves the extremities, abdomen, and groin, but rarely involves the head and neck. Necrotizing fasciitis has an aggressive course; however, in rare cases, it can present in a subacute indolent form which can be misdiagnosed as other cutaneous diseases. Our case is a unique presentation of subacute necrotizing fasciitis of the posterior neck, which was initially diagnosed as a herpes zoster infection, in a patient with undiagnosed diabetes mellitus, which was complicated with diabetic ketoacidosis and sepsis.
Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group
Hoffman, Lindsey M. , Mankad, Kshitij , Kline, Cassie , Ramasubramanian, Aparna , Mangum, Ross , Horne, Vincent E. , Keole, Sameer R., Grosshans, David R. , Packer, Roger J. , Cavalheiro, Sérgio , Hankinson, Todd C. , Warren, Katherine E , Chintagumpala, Murali , Tinkle, Christopher L , Keole, Sameer , Bartels, Ute , Warren, Katherine E , Mangum, Ross , Jaimes, Camilo E. , Mirsky, David M. , Tamrazi, Benita , Malbari, Fatema , Lindsay, Holly , Daniels, David J. , Poussaint, Tina Young , Bison, Brigitte , Muller, Hermann Lothar , Bartels, Ute

Mayo Clinic

Neuro-Oncology | September 15, 2022 | Volume: 25 | Issue: 2 | Pages: 224-233

10.1093/neuonc/noac221 | PMID 36124689 Get It

Abstract Background Craniopharyngioma is a histologically benign tumor of the suprasellar region for which survival is excellent but quality of life is often poor secondary to functional deficits from tumor and treatment. Standard therapy consists of maximal safe resection with or without radiation therapy. Few prospective trials have been performed, and response assessment has not been standardized. Methods The Response Assessment in Pediatric Neuro-Oncology (RAPNO) committee devised consensus guidelines to assess craniopharyngioma response prospectively. Results Magnetic resonance imaging is the recommended radiologic modality for baseline and follow-up assessments. Radiologic response is defined by 2-dimensional measurements of both solid and cystic tumor components. In certain clinical contexts, response to solid and cystic disease may be differentially considered based on their unique natural histories and responses to treatment. Importantly, the committee incorporated functional endpoints related to neuro-endocrine and visual assessments into craniopharyngioma response definitions. In most circumstances, the cystic disease should be considered progressive only if growth is associated with acute, new-onset or progressive functional impairment. Conclusions Craniopharyngioma is a common pediatric central nervous system tumor for which standardized response parameters have not been defined. A RAPNO committee devised guidelines for craniopharyngioma assessment to uniformly define response in future prospective trials.
Abstract A036: Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion
Lavoie, Roxane R. , Gargollo, Patricio C. , Baer, Emily , Phelps, Doris A., Charlesworth, M. Cristine , Hougthon, Peter J., Cheville, John C. , Granberg, Candace F. , Lucien, Fabrice , Ahmed, Mohamed E. , Kim, Yohan , Madden, Benjamin , Wang, Liguo , Dong, Haidong

Mayo Clinic

Clinical Cancer Research | September 15, 2022 | Volume: 28 | Issue: 18_Supplement | Pages: A036-A036

10.1158/1557-3265.sarcomas22-a036 Get It

Abstract Introduction: Pediatric rhabdomyosarcoma (RMS) is the most common soft tissue tumor in children, with nearly 20% of children presenting with locally aggressive and/or metastatic disease. Despite aggressive chemotherapy and radiotherapy, the 5-year overall survival rate is still less than 40%. In addition, resistance to chemotherapy remains the major cause of cancer-related mortality. Therefore, there is an unmet need to develop more effective and tolerable therapeutic strategies for the treatment of RMS. Our overall objective is to leverage transcriptomic and proteomic profiling methods to identify RMS-specific surface proteins targetable with immune-based therapies. Methods: To identify therapeutic targets, we performed cell-surface capture and mass spectrometry on fusion-positive (FP), fusion-negative (FN) RMS and normal skeletal muscle. Transcriptomic datasets of RMS tumor specimens and normal tissue were employed to identify high-confidence RMS-specific cell-surface proteins. Expression of immune checkpoint molecules was confirmed by flow cytometry, western blot and PCR. Paraffin-embedded tissue sections were used to determine protein expression and prognostic value in RMS patients. We developed an in vitro T-cell killing assay to assess the functional role of immune checkpoint molecules on the antitumor immune response. Results: Surfaceome profiling of RMS cells revealed unique protein signatures specific for each tumor type and normal tissue. We have identified 5061 cell-surface proteins in RMS and 31.6% of proteins were correctly located at the plasma membrane. By integrating proteomic and transcriptomic data, we have identified 30 and 38 proteins significantly overexpressed in fusion-negative and fusion-positive RMS respectively compared to normal muscle. We have identified the immune checkpoint molecule B7-H3 as cell-surface protein overexpressed in both RMS subtypes. Strong expression of B7-H3 was also observed in patient’s tumor specimens. Genetic deletion of B7-H3 gene in RMS cells was associated with higher antitumor immune response in tumor cells co-cultured with CD8+-T cells. No difference was observed in tumor cell proliferation and radioresistance. Conclusions: Through integrated transcriptomic and proteomic profiling, we have discovered B7-H3 as a key regulator of tumor immune-evasion in RMS. B7-H3 is a suitable immunotherapy target for the treatment of RMS. Further studies are warranted to elucidate underlying mechanisms of B7-H3 function in RMS. Citation Format: Roxane R. Lavoie, Fabrice Lucien, Patricio C. Gargollo, Mohamed E. Ahmed, Yohan Kim, Emily Baer, Doris Phelps, Cristine M. Charlesworth, Benjamin J. Madden, Liguo Wang, Peter J. Hougthon, John Cheville, Haidong Dong, Candace F. Granberg. Surfaceome profiling of rhabdomyosarcoma reveals B7-H3 as a mediator of immune evasion [abstract]. In: Proceedings of the AACR Special Conference: Sarcomas; 2022 May 9-12; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2022;28(18_Suppl):Abstract nr A036.
A Rare Case of Longitudinally Extensive Transverse Myelitis Following Pfizer-BioNTech COVID-19 Vaccination with a Favourable Outcome
KC, Ojbindra , Dahal, Punya Hari, Koirala, Manisha, Yadav, Sumeet Kumar

Mayo Clinic

European Journal of Case Reports in Internal Medicine | September 15, 2022 | Volume: 9 | Issue: 9 | Pages: No page available

10.12890/2022_003553 | PMID 36299842 Get It

Introduction: mRNA COVID-19 vaccines are very safe, but rare adverse events such as transverse myelitis have been reported after COVID-19 vaccination. Case Description: We report the case of 50-year-old man who presented with progressive lower extremity weakness, back pain and urinary retention after his second dose of the Pfizer COVID-19 vaccine. MRI of the spine revealed longitudinally extensive transverse myelitis (LETM). He recovered completely after treatment with intravenous methylprednisone and physical therapy. Discussion: This case highlights the rare association between LETM and COVID-19 vaccines and encourages clinicians to maintain a high index of suspicion for prompt diagnosis and treatment.